Two Sigma Advisers
QGENF

Two Sigma Advisers’s QIAGEN NV QGENF Stock Holding History

Two Sigma Advisers’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-375,531
Closed -$10.5M – 2585
2016
Q4 		$10.5M Buy
375,531
+166,230
+79% +$4.66M 0.04% 460
2016
Q3 		$5.74M Buy
209,301
+30,286
+17% +$831K 0.02% 602
2016
Q2 		$3.9M Sell
179,015
-23,483
-12% -$512K 0.02% 630
2016
Q1 		$4.52M Buy
+202,498
New +$4.52M 0.03% 532
2015
Q3 		– Sell
-13,009
Closed -$322K – 2206
2015
Q2 		$322K Buy
13,009
+3,720
+40% +$92.1K ﹤0.01% 1590
2015
Q1 		$234K Buy
+9,289
New +$234K ﹤0.01% 1683
2014
Q1 		– Sell
-23,712
Closed -$565K – 2774
2013
Q4 		$565K Buy
+23,712
New +$565K 0.01% 1523

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Two Sigma Advisers's QGENF Position: Q1 2017 in Review

Two Sigma Advisers sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 375,531 shares — an estimated $10.5M sold.

Two Sigma Advisers first reported a position in QGENF in Q4 2013 and held it in 7 quarters. The position peaked at $10.5M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Two Sigma Advisers reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Two Sigma Advisers sold 375,531 QIAGEN NV shares in Q1 2017, an estimated $10.5M.
  • Two Sigma Advisers first reported a position in QIAGEN NV in Q4 2013 and held it in 7 quarters.
  • Two Sigma Advisers's QIAGEN NV position peaked at $10.5M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Two Sigma Advisers's 13F filing for Q1 2017, filed 15 May 2017.